LeMaitre Vascular, Inc. (NasdaqGM: LMAT) $65 Million Senior Secured Credit Facilities

June 24, 2020

On June 22, 2020, KeyBanc Capital Markets Inc. (“KBCM”) successfully closed $65 million of Senior Secured Credit Facilities for LeMaitre Vascular, Inc. (“LMAT” or the “Company”), consisting of a $25 million Revolving Credit Facility and $40 million Term Loan Facility (the “Credit Facilities”). Proceeds from the Credit Facilities will be used primarily to finance the acquisition of Artegraft, Inc. (“Artegraft”) and for general corporate purposes. KBCM acted as the Joint Lead Arranger, Joint Bookrunner and Administrative Agent on the Company’s inaugural syndicated transaction and successfully syndicated this underwritten transaction amidst COVID-19 and its impact on the capital markets. KBCM was hired to lead this transaction due to its strong relationship with the Company, extensive healthcare industry knowledge, and capital markets expertise.

LMAT is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, vascular surgeons. The Company’s diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart.

Artegraft processes and sells biologic vascular grafts that are derived from bovine carotid arteries and are implanted primarily in hemodialysis access patients.

For more information, please contact:

John V. Soden

Managing Director
(415) 962-2922

Steven Alcauskas

Managing Director
(503) 821-3999